Kevin Trapp serves as Chief Commercial Officer and is a member of DBV’s Executive Committee, leveraging his extensive portfolio management experience to oversee all global commercial operations. Prior to joining DBV in August 2018, Mr. Trapp served in a variety of leadership positions during a more than 25-year career at Bristol-Myers Squibb in the areas of finance, sales, marketing and general management, with his last position as Senior Vice President, Portfolio & Access Strategy. Over the course of his career, Mr. Trapp has been responsible for a $4 billion U.S. portfolio in the areas of immunology, neuroscience and virology and was directly involved in launching more than 10 products and indications for leading brands.

Mr. Trapp received his bachelor’s degree from the University of Connecticut School of Business and completed the General Management Program from CEDEP at INSEAD, Fountainebleau, France.